Extense Pharma 1A

Loan Belgium 135 investors
Your partner in nutrition
Investment type
2 years
Investment duration
219,000 €
Amount raised
Gross interest rate
0 days
  • AAA
  • AA
  • A
  • BBB
  • BB
  • B
  • CCC/C
Speculative credit quality
Borrower is less vulnerable in the near term than other lower-rated obligors. However, it faces major ongoing uncertainties and exposure to adverse business, financial, or economic conditions that could lead to the its inadequate capacity to meet its financial commitments.
146% funded
This campaign has been closed

Description of the Loan

The Extense Pharma Participatory Notes offered to the crowd as part of this investment have the following characteristics:

  • Total Amount: Based on the results of subscription to the Extense Pharma Notes, the principal amount of the loan that Spreds Finance will grant to Extense Pharma will be a minimum of € 150,000 and a maximum of € 400,000.
  • Participatory notes: 100 € per note with a minimum of 500 €
  • Annual rate: Expected annual gross interest rate of 8% from the date of withdrawal
  • Loan withdrawal date: Expected to be April 5, 2019
  • Loan duration: maximum 2 years
  • Terms:
    - The loan is "bullet", which means that the principal must be repaid at maturity. In principle, and if Extense Pharma meets all of its payment obligations, the maturity date of the notes should be April 5, 2021.
    - Reimbursement in annuities
  • Conditions precedent: the Loan is granted under the condition precedent of the subscription of Notes participatives for a total amount at least equal to the minimum amount of the offer as described herein; and under the condition precedent that the Loan will be used solely for the purpose of working capital requirements.
  • No dividend payment before repayment of the Loan.
  • No new debt can be contracted before repayment of the Loan.